Near-infrared fluorescence tomography using molecularly targeted lifetime-sensitive, fluorescent contrast agents have applications for early-stage cancer diagnostics. Yet, although the measurement of fluorescent lifetime imaging microscopy ͑FLIM͒ is extensively used in microscopy and spectroscopy applications, demonstration of fluorescence lifetime tomography for medical imaging is limited to two-dimensional studies. Herein, the feasibility of three-dimensional fluorescencelifetime tomography on clinically relevant phantom volumes is established, using ͑i͒ a gainmodulated intensified charge coupled device ͑CCD͒ and modulated laser diode imaging system, ͑ii͒ two fluorescent contrast agents, e.g., Indocyanine green and 3-3'-Diethylthiatricarbocyanine iodide differing in their fluorescence lifetime by 0.62 ns, and ͑iii͒ a two stage approximate extended Kalman filter reconstruction algorithm. Fluorescence measurements of phase and amplitude were acquired on the phantom surface under different target to background fluorescence absorption ͑70:1, 100:1͒ and fluorescence lifetime ͑1:1, 2.1:1͒ contrasts at target depths of 1.4-2 cm. The Bayesian tomography algorithm was employed to obtain three-dimensional images of lifetime and absorption owing to the fluorophores.
I. INTRODUCTION
Optical-based molecular imaging and tomography using near-infrared ͑NIR͒ fluorescent contrast agents represents an emerging technology, which may advance cancer diagnostic imaging. In optical imaging, NIR light between 700-900 nm wavelengths propagates deeply into tissues and can differentiate diseased from normal tissues based on the differences in the endogenous absorption owing to oxy-and deoxyhemoglobin, as demonstrated from breast imaging studies. [1] [2] [3] [4] [5] [6] [7] In order to increase the optical detection of small tissue lesions not contrasted by neovascularization, molecular targeting and reporting fluorescent contrast agents have been developed. These agents can potentially improve the target:background ͑T:B͒ optical contrast ratio between normal and diseased tissues with greater specificity and sensitivity over optical imaging performed using endogenous absorption contrast alone. [8] [9] [10] In recent years, three-dimensional ͑3D͒ fluorescenceenhanced optical tomography has been developed for timedependent and time-independent measurements of light propagation for in vivo small animal studies 11, 12 and large phantom studies. [13] [14] [15] [16] [17] [18] [19] All developments have been based upon T:B contrast due to fluorophore absorption cross section. Yet fluorescence offers the added capability of determining lifetime or radiative decay kinetics as a method for assessing the local environmental conditions independent of fluorophore concentration. 20, 21 Hence, by employing lifetime-sensitive fluorescing contrast agents, tomographic analysis of the fluorescence measurements may differentiate diseased tissues from normal tissues. Pioneering work to develop "reporting" fluorophore-protein conjugate contrast agents that demonstrate changes in fluorescence decay kinetics in the presence of specific proteases has been reported by Weissleder and colleagues [22] [23] [24] and is the subject of development in other laboratories. 25 Tomographic imaging of fluorescence lifetime in 2D [26] [27] [28] and 3D 29, 30 has been demonstrated from time-dependent simulated measurements. While 3D tomographic reconstruction of lifetime-sensitive fluorophore absorption cross section has been experimentally reported from time-independent measurements on small animals, 31 fluorescence lifetime tomography has been limited to 2D experimental studies using time-dependent measurement schemes. 32 To date, 3D fluorescence lifetime tomography has not been demonstrated using experimental measurements, but has been limited to simulated studies. 29, 30 In this contribution, the feasibility of 3D fluorescence lifetime tomography is demonstrated on clinically relevant tissue phantoms using fluorescent contrast agents differing in their fluorescence optical properties and time-dependent ͑frequency-domain͒ fluorescence measurements. Clinical translation of 3D fluorescence lifetime tomography will require both: ͑i͒ the development of lifetime sensitive fluorescent contrast agents, which "report" environmental conditions through a change in decay kinetics and ͑ii͒ the development and demonstration of a tomography algorithm that can reconstruct the 3D distribution of spatially-varying fluorescence lifetime from experimental measurements ͑us-ing clinically relevant volumes͒. While the former is a subject of active research in a variety of laboratories, [22] [23] [24] the focus of the current work is the latter. Herein, we use two dyes whose decay properties ͑in terms of fluorescence lifetime and quantum efficiency͒ are known and constant in order to assess the success of the reconstruction algorithm in identifying regions of varying fluorescence lifetime.
Experiments were performed under various conditions of T:B optical contrast ratios in fluorescence absorption ͑con-centration͒ and lifetime using two contrast agents ͑Indocya-nine Green, ICG, and 3-3' Diethylthiatricarbocyanine Iodide, DTTCI͒ similar in their excitation and emission spectra ͑780 and 830 nm, respectively͒, but different in their fluorescence lifetime. A 3D image reconstruction algorithm was developed using a two-stage Bayesian approximate extended Kalman filter ͑AEKF͒. Reconstruction of both fluorescence lifetime and absorption cross-section contrast was investigated, and the results demonstrate the feasibility of 3D fluorescence lifetime tomography.
II. MATERIALS AND METHODS

A. Breast-mimicking phantoms
Experimental studies were carried out using a hollow breast-shaped phantoms ͑10 cm diameter hemispherical phantom "breast" atop a 20 cm cylindrical base phantom "chest wall" as shown in Fig. 1͒ filled with 1087 cm 3 of a fatty emulsion solution ͑1% Liposyn, Abbott Laboratories, North Chicago, IL͒, with optical properties ͑experimentally acquired 33 ͒ similar to those of the normal human breast tissue.
In order to demonstrate the potential benefit of future lifetime-sensitive dyes currently under development, two well-characterized NIR dyes of known and constant lifetime ͑that mimic the fluorescence decay kinetic change between a target and its surroundings͒ were chosen for our tomographic imaging studies under well-controlled conditions in a clinically relevant breast phantom. The fluorophores used were ͑i͒ ICG stabilized with sodium polyaspartate ͑MW 3000-8000͒ ͑Sigma-Aldrich Chemical Co., St. Louis, CO͒ 34 and diluted in deionized water and 1% Liposyn solution, and ͑ii͒ DTTCI diluted in dimethyl sulfoxide and 1% Liposyn solution. The dyes were used in appropriately contrasting micromolar concentrations in the background of the phantom and inside a 1 cm 3 clear acrylic target suspended inside the hemispherical portion of the phantom. ICG and DTTCI were chosen primarily because their fluorescent decays are well described by single-exponential decay functions, 20 and the two contrast agents have a roughly twofold difference in fluorescence lifetime, ͑ ICG = 0.56 ns, DTTCI = 1.18 ns͒. 34 Since ICG and DTTCI excite and emit at similar wavelengths, but have different fluorescence lifetime ͑͒, they were used in different T:B fluorescence absorption ͑70:1, 100:1͒ and life- time contrast ratios ͑1:1, 2.1:1͒, and target depths ͑1.4-2 cm͒ in order to perform experimental studies under three different cases as shown in Table I . The background optical properties of the 1% Liposyn solution in the phantom are provided for each experimental case in Table II . ICG and DTTCI also have differing quantum efficiency, ͑ ICG = 0.016, DTTCI = 0.034͒. However, the quantum efficiency of the dye placed in the acrylic target was reduced by 32% due to the transmission efficiency of the acrylic container, leading to a small T:B contrast in the current studies ͑0.68:1 for Cases 1 and 2, and 1.44:1 for Case 3͒. Hence, the T:B contrast in quantum efficiency was neglected in the current studies and is further described in Sec. II C.
B. Instrumentation
Time-dependent measurement techniques ͑i.e., time-or frequency-domain͒ are required for lifetime imaging, since the fluorescence lifetime information is preserved as delayed pulse time in the time-domain method, or as phase shift measurements in frequency-domain method ͑as employed in our current studies͒.
Herein, frequency-domain photon migration ͑FDPM͒ fluorescence measurements were obtained from the hemispherical surface of the clinically relevant phantom. Initially, modulated excitation light at 100 MHz was used to sequentially illuminate the phantom surface ͑783 nm͒ via 27 multimode optical fibers ͑1 mm diameter, model FT-1.0-EMT, Thorlabs Inc., NJ͒. The modulated excitation light propagated in the phantom medium and upon encountering the fluorescent molecules, generated modulated fluorescence signals ͑100 MHz, 830 nm͒, which further propagated in the phantom medium before they were simultaneously collected from various locations on the phantom surface via 128 multimode optical fibers. The free ends of the optical fibers collecting the fluorescence light on the phantom surface were mounted as 2D arrays on two interfacing plates ͑64 collection fibers each͒, which were imaged using a gain-modulated intensified charge coupled device ͑ICCD͒ camera ͑i.e., optically coupled image intensifier and CCD camera͒. An optical filter assembly containing appropriate filters ͑830-nm interference filter and holographic notch filter͒ was used to minimize the excitation light leakage, rejecting light outside the bandwidth of the emission wavelength; thus allowing predominantly the fluorescence light to be imaged by the photocathode of the image intensifier. The photocathode of the image intensifier ͑FS9910C, ITT Night Vision, VA͒ was modulated at the same frequency ͑100 MHz͒ as the incident NIR excitation light. The acquired modulated fluorescence signal was collected as steady-state intensity signal by the integrating CCD camera ͑CCD-512-EFT Photometric CH12, Roper Scientific, Trenton, NJ͒ via homodyne mixing techniques and low pass filtering caused by the slow phosphor output of the image intensifier. The phosphor output was sensitive to the phase delay existing between the two phaselocked oscillators ͑Marconi Instruments model 2022D, UK; and Programmed Test Sources model 310M201GYX-53, Littleton, MA͒ that modulated the incident NIR excitation light and the photocathode of the image intensifier, respectively. By varying the phase delay between the two oscillators from 0 to 2, the steady-state intensities at each pixel of the CCD image varied sinusoidally. Upon performing fast Fourier transforms to the acquired CCD images, measurements of amplitude ͑I ac ͒ and phase shift ͑͒ of the fluorescence signal at each collection fiber location were acquired. Five sets of images of the interfacing plates were acquired and averaged in order to assess as well as reduce the measurement error of the imaging system. The fluorescence measurements acquired from each interfacing plate ͑i.e., 64 collection fibers͒ and for a given point source illumination, were referenced ͑by dividing each measurement with respect to the measurement containing the maximum fluorescence I ac ͒ in order to account for the instrument effects.
14,16-18 These referenced fluorescence measurements were thus used in terms of ͑i͒ the logarithm of the referenced amplitude, denoted by ln ͑ACR͒ and ͑ii͒ the referenced phase shift, denoted by RPS, during image reconstructions. Only measurements above the noise floor ͓modulation depth ͑ac/dc͒ ജ0.025͔ were employed during image reconstructions. A schematic of the instrumentation is shown in Fig. 1 . Further details about the instrument setup and the data acquisition procedures are provided elsewhere.
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C. Image reconstruction algorithm
FDPM fluorescence measurements were collected in response to sequential NIR point source illuminations and inverted to tomographically estimate 3D spatial distributions of the fluorescence optical properties using the coupled diffusion equations [35] [36] [37] ͑see Appendix A for details͒ and a computationally efficient variant of the approximate extended Kalman filter ͑AEKF͒ algorithm, as described below.
A dynamic recursive estimate of the unknown parameters ͑i.e., fluorescence optical properties͒ and the parameter error variances were evaluated using ͑i͒ experimental referenced measurements regularized by empirically determined measurement error variance ͑i.e., variance of the repeated measurements͒, ͑ii͒ a static estimate of model error variance ͑es-timated to be 1 / 4 of the mean of measurement error variance͒, and ͑iii͒ a forward simulator that computes predicted referenced measurements by employing a diffusion approximation of the coupled radiative transport equations for excitation and emission light. [35] [36] [37] The forward simulator ͑see Appendix A for details͒ was implemented using a fast vectorized finite element technique 38 containing 6956 nodes, of which only parameters associated with the n = 3857 nodes in the hemispherical portion of the model were allowed to vary ͑i.e., the number of unknowns during reconstruction of each optical parameter was 3857͒. Given the estimates of the measurement error, model error, and initial parameter estimation errors, the AEKF algorithm minimizes the parameter error variance, as opposed to simply minimizing the parameter error, thereby regularizing this ill-posed problem in a Bayesian manner. Details of the AEKF algorithm used in the current study are provided as supplemental information ͑Ap-pendix B͒ and are further elaborated elsewhere. 14, 16, 28 The source of fluorescence emissions is governed by the spatial distribution of fluorescence absorption cross-section ͑ a x→m ͒, fluorescence lifetime ͑͒, and quantum efficiency ͑͒ ͑as shown in Eq. ͑A2͒ of Appendix A͒. Spatial variance in a x→m ͑i.e., the amount of absorption and quantum efficiency of the dye͒ predominantly influences the fluorescence amplitude measurements ͑in frequency-domain imaging system͒, since a x→m and determine the intensity of the emitted fluorescence in the presence of an excitation light source. On the other hand, spatial variance in the fluorescence lifetime predominantly impacts the phase-delay ͑͒ of the fluorescent source, i.e., ϳ tan −1 ͑͒, in a frequency-domain system with frequency. 39 Hence fluorescence amplitude measurements were used to estimate the spatial distribution of a x→m ͓assuming a homogeneous and constant quantum efficiency ͑͒ distribution͔ and fluorescence phase delay measurements were used to estimate the spatial distribution of . The quantum efficiency distribution was assumed homogeneous and constant because an under-͑over-͒ estimate of fluorescence absorption cross-section compensates for an over-͑under-͒ estimate of quantum efficiency in the emission source term, as both these parameters impact the same measured quantity ͑i.e., fluorescence amplitude͒. However, the T:B contrast in was relatively small ͓0.68:1 for Cases 1 and 2, and 1.44:1 for Case 3 ͑see Sec. II A͔͒ in comparison to the T:B contrast in a x→m ͑100:1 for Cases 1 and 2, and 70:1 for Case 3͒, and hence the assumption of a homogeneous and constant -distribution was considered.
Simultaneous reconstruction of both a x→m and was not carried out since: ͑i͒ a priori knowledge of the fluorescence absorption ͑ a x→m ͒ distribution is significant for estimation of the fluorescence lifetime distrbution, especially when the fluorescence concentration ͑or absorption͒ contrast increases and ͑ii͒ the intense computations prohibited the simultaneous coestimation of two unknown parameters in large phantom volumes. Thus, a two-stage image reconstruction approach ͑see Fig. 2͒ was developed in order to reconstruct a x→m in stage-1 and in stage-2.
In stage-1 reconstructions ͓Fig. 2͑a͔͒, amplitude measurements, ln͑ACR͒ are used to reconstruct the absorption cross section of the fluorophore by ͑i͒ first assuming a low initial estimate in a x→m = 0.001 cm −1 that was different from the true experimental background ͑ a x→m = 0.003 cm −1 ͒ and ͑ii͒ assuming a constant fluorescence lifetime ͑ = 0.56 ns͒ and constant quantum efficiency ͑ = 0.016͒, which are equivalent to the fluorescence properties of the background fluorophores. During stage-1 reconstructions, the AEKF algorithm employed measurements of ln͑ACR͒ in order to estimate the fluorescence absorption cross-section a x→m , which was constrained by means of pseudo-beta transforms 28 In stage-2 reconstructions ͓Fig. 2͑b͔͒, phase shift ͑RPS͒ measurements were used to reconstruction the fluorescence lifetime by ͑i͒ first assuming an initial guess of the fluorescence lifetime ͑͒ equivalent to that of the background fluorophore ͑ = 0.56 ns͒, ͑ii͒ considering the spatial distribution of absorption cross-section a x→m determined from stage-1, and ͑iii͒ assuming a constant quantum efficiency ͑ = 0.016͒ equivalent to the background fluorophore. During stage-2 reconstructions, the AEKF algorithm employed measurements of RPS in order to estimate ͑i.e., product of fluorescence lifetime and modulation frequency ͓ = 100 MHz͔, which was constrained by means of pseudobeta transforms to the range of 0.48Ͻ Ͻ 1.27 ns during inversions. The multiplication of with the constant was used to prevent numerical truncation error. Reconstructions were carried out using a uniform initial parameter variance estimate ͑ 2 = 0.2͒ for the transformed . Stage-2 reconstructions were assumed to have converged when there was less than a 0.5% change in the maximum RPS error between consecutive iterations.
Three-dimensional image reconstructions were carried out on a Dell Workstation PWS650 ͓Xeon͑TM͒ 3.06 GHz, 2.0 GB RAM͔, and required less than 1 s per iteration per fluorescence measurement ͑for a single point source illumination͒, for each stage of the reconstruction. The distribution of the remaining optical parameters, such as ͑i͒ absorption coefficient due to nonfluorescing chromophores and ͑ii͒ scattering coefficients due to fluorophores and nonfluorescing chro- mophores ͓shown in Eq. ͑A2͒ of Appendix A͔, were assumed homogeneous and known ͑Table II͒ for each experimental case and for both the reconstruction stages.
D. Model and measurement error calculation
In any inversion technique, the estimation of the model mismatch errors ͑difference between experimental and simulated measurements͒ is important in validating the light propagation model used in the forward simulator of the reconstruction algorithm. Herein, model mismatch errors in ln͑ACR͒ and RPS were computed for each fluorescence measurement whose measured modulation depth was above the noise floor ͑i.e., ac/dc ജ0.025͒. The mean of the model mismatch error thus represents ͑i͒ model bias and ͑ii͒ any residual bias in the measurement error obtained after averaging the measurement repetitions. Measurement error variances were experimentally estimated as the variance of the mean of five repeated measurements of ln͑ACR͒ and RPS obtained for each fluorescence measurement, whose measured modulation depth was above the noise floor.
III. RESULTS AND DISCUSSION
A. Model and measurement errors
Lumped statistics for both model mismatch and measurement errors are given in Table III . By definition, measurement errors were zero mean, with all bias combined into the mean of the model mismatch error. Model and measurement error variances for ln͑ACR͒ are the same order of magnitude for all three cases. However, when a lifetime contrast was introduced in the tissue phantom ͑Case 3 of Table I͒ , the increase in fluorescence lifetime in the target region resulted in an increase in phase shift at the phantom surface, producing a stronger perturbation in the acquired phase shift signal. Consequently, with lifetime contrast ͑Case 3͒, the RPS variances of both model and measurement errors were reduced by an order of magnitude, relative to the no-lifetime contrast experimental cases ͑Cases 1 and 2 of Table I͒. In experimental cases 1 and 2, all the collection fibers in the region of the target were attached to one interfacing plate, so measurements were made at 64 collection fibers for each source illumination. In Case 3 collection fibers from both the interfacing plates were close to the target, so measurements were made at 128 collection fibers for each source illumination. Thus, the larger number of measurements and the stronger fluorescence signal strength in Case 3 resulted in a larger usable data set than in Cases 1 and 2, as shown in Table III .
B. Three-dimensional fluorescence absorption tomography
In all the three experimental cases, the 3D reconstructed fluorescence absorption a x→m distributions identified the targets close to their true location in the experiments as shown in Fig. 3 as 3D iso-surface plots of the a x→m distribution. All these stage-1 reconstructions converged in 12-13 iterations, and the sum of squared ln͑ACR͒ prediction errors dropped between 86% and 92% in each case ͓see Fig. 4͑a͔͒ . Nonetheless, the reconstructed a x→m T:B ratios were not quantitatively accurate ͑Table IV͒, reflecting the relative insensitivity of this convergence metric to absolute a x→m values. These results are consistent with our earlier studies 14, [16] [17] [18] [19] showing that locations of contrasting fluorescence absorption can be reconstructed with greater accuracy than the absolute values of fluorescence absorption ͑ a x→m ͒. In addition, the assumption of a homogeneous and constant ͑=0.016͒ could possibly account for the overestimation of a x→m values in the Case 3, and the underestimation of a x→m values in Cases 1 and 2. 3 . Three-dimensional iso-surface plots of fluorescence absorption ͑ axf ͒ distributions for ͑a͒ Case 1, ͑b͒ Case 2, and ͑c͒ Case 3. The reconstructed target ͑solid region inside breast phantom͒ was differentiated from background phantom at iso-surface cutoff values of 30% of the maximum reconstructed axf in each case. The true 1 cc volume target is shown by a black wire frame.
C. Three-dimensional fluorescence lifetime tomography
In experimental cases 1 and 2, where there was no T:B fluorescence lifetime contrast, stage-2 reconstructions converged after one iteration, with less than 0.07% change in maximum RPS error ͓see Fig. 4͑b͔͒ and correctly estimated essentially no lifetime contrast ͑Table IV͒, demonstrating the specificity of lifetime-based tomography. In Case 3, where there was a 2.1:1 fluorescence lifetime contrast, stage-2 reconstructions converged in four iterations with a 16.5% decrease in maximum RPS error ͓see Fig. 4͑b͔͒ and reconstructed a 2.2:1 T:B lifetime contrast ratio ͑see Fig. 5 and Table IV͒ . Three-dimensional fluorescence lifetime distributions for Case 3 are shown as a 3D iso-surface plot in Fig.  5͑a͒ and as orthogonal contour slices through the true centroid of the target in Figs. 5͑b͒-5͑d͒. A few heterogeneities were observed in the phantom background ͓see Fig. 5͑c͔͒ , whose maximum reconstructed values were less than 25% of the maximum reconstructed value in the target location. Hence, these heterogeneities were not classified as artifacts ͓Fig. 5͑a͔͒ in the current studies.
In order to test the sensitivity of our stage-2 lifetime reconstructions to the quantitative errors in the stage-1 fluorescence absorption reconstructions, a separate study was carried out. Stage-2 ͑lifetime͒ reconstructions from experimental measurements of RPS were carried out using three levels of assumed T:B a x→m contrasts of ͑i͒ 0.03:0.003, ͑ii͒ 0.3:0.003, and ͑iii͒ 0.7:0.003 ͑all in cm −1 ͒, for all three experimental cases. Except for the assumed T:B a x→m contrast levels in each experimental case, the remaining parameter settings were the same as those described in Sec. II C for stage-2 reconstructions.
The maximum reconstructed T:B fluorescence lifetime contrasts obtained using the assumed ͑and deliberately incorrect͒ T:B a x→m contrast values at various levels are presented as a bar plot in Fig. 6 . It can be seen from the bar plot that the stage-2 lifetime reconstructions detected no lifetime contrast in the target for Cases 1 and 2 ͑suggesting high specificity͒ but detected an elevation in lifetime ͑as expected͒ in the target for Case 3, regardless of the absolute value of T:B a x→m contrast levels assumed. These results further validate that 3D lifetime tomography can detect small ͑2.1:1͒ lifetime contrasts, and is relatively insensitive to the quantitative errors in the reconstructed fluorescence absorption ͑ a x→m ͒. It is worth noting that additional experiments were performed ͑not otherwise reported here͒, where reconstruction of a x→m was performed in stage 1 using both fluorescence amplitude and phase delay measurements. Since the resulting a x→m estimates were very similar to those using amplitude alone, and the subsequent estimates of are insensitive to quantitative errors in a x→m , a more computationally efficient version of stage-1 reconstruction that used only fluorescence amplitude, but not phase delay measurements was employed for the current studies.
IV. SUMMARY AND CONCLUSIONS
The feasibility of 3D fluorescence lifetime tomography in breast phantom volumes was demonstrated using a gainmodulated ICCD imaging system and a two-stage Bayesian reconstruction algorithm. Feasibility studies were carried out both in the presence and absence of fluorescence lifetime contrast in breast phantoms. Fluorescing targets ͑1 cm 3 ͒ containing ICG and/or DTTCI contrast agents were embedded 1.4-2.0 cm below the hemispherical surface of the tissue phantoms ͑1087 cm 3 volume͒ with ͑i͒ T:B absorption contrast of 100:1 ͑Cases 1 and 2͒ or 70:1 ͑Case 3͒ and ͑ii͒ T:B fluorescence lifetime contrast of 1:1 ͑Cases 1 and 2͒ or 2.1:1 ͑Case 3͒. A two-stage reconstruction algorithm was employed to sequentially estimate the spatial distribution of fluorescence absorption followed by fluorescence lifetime, in the entire phantom. All the experimental cases reconstructed the targets close to the actual target locations, based on contrast observed in both a x→m and distributions. The insensitivity of 3D lifetime tomography to the quantitative errors in a x→m distributions was also demonstrated.
Herein, we have presented a three-dimensional tomographic analog to 2D fluorescence lifetime imaging microscopy that could extend measurement of fluorescence lifetime of NIR fluorophores deep into tissues and other scattering media. Fluorescence lifetime tomography makes possible the detection of changes in fluorescence resonance energy transfer between donor-acceptor pairs tethered on proteasespecific peptides or receptor ligands as well as the quenching of closely tethered fluorophores that can act as "beacons" upon enzyme-specific cleavage of fluorophores. [22] [23] [24] Future work involves determining the minimal fluorescence lifetime contrast required for tomographic imaging as well as the relationship of modulation frequency, depth, and size upon target detectability. Based on these initial phantom studies, there is demonstrated, potential benefit to develop and translate lifetime sensitive agents for in vivo diagnostic imaging.
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APPENDIX A
Light propagation and fluorescence generation in tissues can be described using the coupled diffusion equation that represents the light propagation at excitation and emission wavelengths, respectively. At a given modulation frequency of light, f͑ =2f radians͒, the coupled diffusion equation is given by [35] [36] [37] 
In the above equations, ⌽ x and ⌽ x are the ac components of the excitation and emission fluence ͑photons/ s cm 2 ͒ respectively; D is the diffusion coefficient ͑cm −1 ͒; axi is the absorption coefficient due to the chromophores ͑cm −1 ͒ ͑i.e., the endogenous chromophores in tissues͒; a x→m is the absorption cross section due to the fluorophores ͓i.e., exogenous fluorescing agents ͑cm −1 ͔͒; am represents the absorption coefficient of the emission light due to the chromophores ͑cm −1 ͒; and and denote the quantum efficiency and lifetime ͑ns͒ of the fluorophore, respectively. The terms c x and c m represent the velocity of light at excitation and emission wavelengths ͑cm/s͒; corresponds to the modulation frequency of propagating light ͑=2f rad͒; and r and r s are the positional vectors at a given point and source illumination point, respectively. The excitation fluence ⌽ x couples the diffusion Eqs. ͑A.1͒ and ͑A.2͒. In the frequencydomain, fluence at excitation and emission wavelengths are given by ⌽ x = I ac,x exp͑i x ͒ and ⌽ m = I ac,m exp͑i m ͒, respectively. Here I ac is the amplitude and is the phase shift at excitation ͑suffix "x"͒ and emission ͑suffix "m"͒ wavelengths, respectively.
The forward model of the light propagation in 3D is solved using the Galerkin approximation of the finite element method and the partial current boundary conditions. 38 Here, all the optical properties of the tissue medium and the fluorescing agent are assumed to be known a priori, and the fluence is calculated in terms of amplitude and phase shift. Having validated the coupled diffusion equations for the current experimental data ͑by comparing the experimental data to the simulated measurements͒, 3D image reconstructions were carried out using the AEKF algorithm ͑described in Appendix B͒.
APPENDIX B
Three-dimensional image reconstructions were carried out using a computationally efficient variant of the approximate extended Kalman filter ͑AEKF͒ algorithm, which is shown by a generic pseudo-code in Fig. 7 . Initially the unknown parameter ͑here, transformed fluorescence absorption or lifetime͒ updates ͑given by ⌬y͒ are initialized ͑line 2͒. The forward simulator, f ͑line 4͒ computes predictions of ln͑ACR͒ and RPS ͑given by x͒ at various locations ͑1 to m s ͒ of de-tected measurements of ln͑ACR͒ and RPS ͑given by z s ͒, in response to a given excitation source illumination ͑subscript s͒ and using the current estimates ͑i.e., initial estimates in the first iteration͒ of unknown optical parameters ͑given by y͒. Parameter updates ⌬y were computed ͑line 7͒ by weighting discrepancies between measurements ͑z s ͒ and predictions ͑x͒, based on a nearly-optimal gain matrix ͑K͒. The gain matrix ͑K͒ was computed ͑line 6͒ from the Jacobian sensitivity matrix ͑J͒ ͑line 5͒ using a Bayesian minimum-variance nonlinear least-squares formulation that was damped by the inverse of a recursively updated ͑line 8͒ parameter error covariance ͑P͒, and weighted by the inverse of the sum of the experimentally determined measurement error covariance ͑R s ͒ and an estimate of the model error covariance ͑Q s ͒. After all sources have contributed to the parameter update ⌬y ͑loop 3-9͒, the parameter y is updated ͑line 11͒. This implementation of the AEKF is an approximation to the optimal ͑minimum-variance͒ estimate in that ͑i͒ we ignore spatial cross covariances ͑i.e., P, Q, and R are diagonal matrices, hence the update of only the diagonal elements of P in line 8͒ and ͑ii͒ we have decomposed the data by source ͑loop 3-9͒ in order to reduce memory requirements. Additional details on the forward simulator and adjoint sensitivity calculations 19, 38 and AEKF 14, 16, 28 are provided elsewhere. 
